Inflating the Donor Site: Simple Fluid Injection Helps Skin Grafts Take Hold and Heals Wounds Faster

Split-thickness skin grafting is one of the most frequently performed reconstructive procedures in modern surgery, used to close burns, chronic ulcers, traumatic wounds and surgical defects that cannot heal on their own. Yet for all its routine status, the operation carries a persistent burden that surgeons have struggled to eliminate: the donor site, the strip of skin from which the graft is shaved, often bleeds, hurts and heals slowly. A new prospective observational study from a tertiary care hospital in India adds fresh, quantitative weight to an idea that has been circulating in surgical circles for decades — that injecting a dilute mixture of local anesthetic and adrenaline into the donor area before harvesting, the so-called tumescent technique, can meaningfully improve outcomes for patients.

The study, published in the Archives of Dermatological Research, enrolled 140 patients with clean, granulating wounds who were candidates for split-thickness skin grafting between July 2024 and November 2025. Participants were divided into two groups of 70 according to the harvesting technique used by the operating surgeon. Group A underwent the tumescent technique, in which a super-wet infiltration of dilute anesthetic solution was injected into the donor site before the dermatome was run. Group B underwent the traditional non-tumescent technique, in which the graft is harvested without prior infiltration. Grafts were taken at a standardized thickness in both arms, and the researchers tracked three primary endpoints: the percentage of graft acceptance at day 5, day 10 and week 3; donor-site healing at day 10 and week 3; and postoperative pain measured with the Visual Analogue Scale.

The results favored the tumescent approach at every measured time point. Graft acceptance in the tumescent group reached 97.5 percent at day 5 compared with 94.0 percent in the non-tumescent group, 94.9 percent versus 88.9 percent at day 10, and 88.0 percent versus 83.1 percent at week 3, with all differences statistically significant at p less than 0.001. In practical terms, that gap means fewer patients returning to the operating room for revision grafting, fewer days of open wound care and a shorter, less costly hospital course. Graft take — the process by which a transplanted sheet of skin reattaches to its new bed through revascularization — is notoriously sensitive to conditions at the recipient site, and any intervention that nudges acceptance upward by several percentage points is clinically meaningful.

Even more striking were the differences at the donor site itself. By day 10, 87.1 percent of tumescent patients had achieved complete healing of the harvest wound, compared with 70.0 percent of those in the conventional group, a difference the authors report as significant at p equal to 0.013. The divergence widened further: the entire tumescent arm achieved complete donor-site healing within one to two weeks, whereas only 31.4 percent of the non-tumescent arm had done so by the same interval, a difference with a p value below 0.001. Epithelialization — the migration of new skin cells across the raw surface left by the dermatome — is the rate-limiting step in donor-site recovery, and accelerating it by even a few days can translate into less dressing changes, less nursing time and a faster return to normal activity.

Pain, the symptom patients most dread after graft harvesting, also fell decisively in the tumescent group. Postoperative analgesia requirements were significantly reduced compared with the conventional arm, with a p value below 0.001 on the Visual Analogue Scale comparisons. The mechanism is straightforward pharmacology: the tumescent solution contains a local anesthetic, typically lidocaine in dilute concentration, which bathes the nerve endings in the dermis and subcutaneous tissue and blocks pain signaling at the source. Because the solution is injected in large volume under low pressure — the super-wet approach — it also physically distends the tissue, firming the donor surface so the dermatome can cut a smoother, more uniform graft with less mechanical trauma.

Adrenaline, the second key ingredient in the infiltrate, does the hemostatic work. By constricting the small dermal vessels that bleed freely when the skin is shaved, it dries the donor field, reduces intraoperative blood loss and may improve the visibility and precision of the harvest. The concept is not new: the tumescent technique was originally described in 1987 for liposuction surgery, where large volumes of dilute anesthetic and adrenaline are infiltrated into subcutaneous fat, and it has since been adapted for a range of dermatosurgical procedures. Burn surgeons in particular have reported that tumescent infiltration significantly reduces blood loss during excision of burn wounds, and several smaller comparative studies have suggested benefits for skin graft harvesting specifically.

What sets the new study apart is its prospective design and its size relative to much of the earlier literature. Previous comparisons of tumescent and non-tumescent graft harvesting have often been retrospective, single-arm or small cross-sectional analyses. By enrolling 140 patients consecutively at a single tertiary care facility, standardizing graft thickness across both groups and pre-specifying objective endpoints at fixed time points, the Indian team produced one of the more rigorous datasets on the question to date. Complications told a consistent story: overall complications occurred in 7.1 percent of the tumescent group versus 20.0 percent of the non-tumescent group, a difference the authors report as statistically significant at p equal to 0.048. The reduction was driven primarily by graft loss, which fell from 10.0 percent in the conventional arm to 1.4 percent in the tumescent arm, significant at p equal to 0.011.

The biological logic behind these numbers is plausible on several fronts. A drier, better-hemostased donor bed may allow the harvested graft to be handled and applied with less contamination by blood, which can lift the graft off the recipient bed and prevent the capillary ingrowth required for take. The vasoconstriction induced by adrenaline may also create a transient ischemic stimulus at the donor site that some investigators believe accelerates re-epithelialization, although the precise mechanism remains debated. There is even laboratory evidence that tumescent infiltration fluid has antibacterial properties, which could reduce low-grade infection at both the donor and recipient sites. And because the anesthetic effect persists into the immediate postoperative period, patients start their recovery with better-controlled pain, which itself supports mobilization, sleep and wound perfusion.

The authors are careful about the limits of their evidence. As a prospective observational study rather than a randomized controlled trial, allocation to the two techniques followed the practice of the operating surgeon rather than a random process, leaving open the possibility of selection bias — for example, if surgeons preferentially used tumescence in patients they judged better candidates. The analysis relied on Student’s t-test and the chi-square test with a significance threshold of p less than 0.05, and while the differences in graft take and donor healing were large and consistent, observational designs cannot fully exclude confounding by surgeon skill, wound characteristics or adjunctive care. The authors themselves conclude that these encouraging findings warrant broader evaluation in prospective randomized controlled trials before the tumescent technique is definitively integrated into standard clinical practice.

Still, the direction of the evidence is hard to ignore. A technique that costs little more than a syringe, a dilute anesthetic solution and a few minutes of infiltration time delivered measurable gains in graft survival, donor-site healing speed, pain control and complication rates across 140 patients. For burn units, wound centers and plastic surgery services in resource-constrained settings — where revision surgery and prolonged dressing care carry the heaviest costs — a low-tech intervention with this effect profile could change routine practice. If randomized trials confirm what this observational study suggests, the humble act of inflating the donor site with fluid before cutting may become as standard a step in skin grafting as the dermatome itself.

Subject of Research: Comparison of tumescent and non-tumescent techniques for split-thickness skin graft harvesting and donor-site outcomes

Article Title: Tumescent vs. non-tumescent techniques for split-thickness skin grafting: a prospective observational study

Article References: Kambaiahgari, M. M. R., Sivamurugan, A., Pravin Dhas, A., Debarath Das, D., & Raman, L. (2026). Tumescent vs. non-tumescent techniques for split-thickness skin grafting: a prospective observational study. Archives of Dermatological Research, 318(1), Article 482. https://doi.org/10.1007/s00403-026-04878-z

Image Credits: AI Generated

DOI: 10.1007/s00403-026-04878-z

Keywords: split-thickness skin graft, tumescent technique, donor site healing, graft take, postoperative pain, adrenaline infiltration, local anesthesia, epithelialization, burn surgery, reconstructive surgery, dermatological research, surgical outcomes